Analysis of Blood Aminophylline Concentration Monitoring in 228 Patients
Zhigang Zhao
Abstract
Zhigang Zhao
Abstract
OBJECTIVE:To give some information for a rational administration of aminophylline for patients and put forward individual does proposal by the analysis on blood drug concentration of aminophylline of 228 cases. METHODS:plasma aminophylline concentration monitoring materials and relevant clinical information were analyzed of 228cases. RESULTS:Plasma aminophylline concentration were range of 5~20 μg·mL-1 in patients,accounting for 20.6% of total cases observed,more than 20 μg·mL-1 in patients,accounting for 3.5%,and lower than 5 μg·mL-1 in patients,accounting for 75.9%. Clinical manifestation in digestive,circulatory,and nervous systems et al can be observed in patients with plasma aminophylline concentration were more than 20 μg·mL-1. Significant change of plasma aminophylline concentration can be observed in patients who combine aminophylline and other kinds of drug. CONCLUSION:Plasma aminophylline concentration should be monitored in clinical usage and the influencing factors,such as physical,pathology and combing usage should be noticed closely.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To give some information for a rational administration of aminophylline for patients and put forward individual does proposal by the analysis on blood drug concentration of aminophylline of 228 cases. METHODS:plasma aminophylline concentration monitoring materials and relevant clinical information were analyzed of 228cases. RESULTS:Plasma aminophylline concentration were range of 5~20 μg·mL-1 in patients,accounting for 20.6% of total cases observed,more than 20 μg·mL-1 in patients,accounting for 3.5%,and lower than 5 μg·mL-1 in patients,accounting for 75.9%. Clinical manifestation in digestive,circulatory,and nervous systems et al can be observed in patients with plasma aminophylline concentration were more than 20 μg·mL-1. Significant change of plasma aminophylline concentration can be observed in patients who combine aminophylline and other kinds of drug. CONCLUSION:Plasma aminophylline concentration should be monitored in clinical usage and the influencing factors,such as physical,pathology and combing usage should be noticed closely.
Key concepts: Aminophylline, Plasma concentration, Medicine, Anesthesia, Pharmacology